159 related articles for article (PubMed ID: 22765891)
1. Synthesis and antibacterial activity against Clostridium difficile of novel demethylvancomycin derivatives.
Zhang SJ; Yang Q; Xu L; Chang J; Sun X
Bioorg Med Chem Lett; 2012 Aug; 22(15):4942-5. PubMed ID: 22765891
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
[TBL] [Abstract][Full Text] [Related]
3. Solid-phase synthesis and antibacterial evaluations of N-demethylvancomycin derivatives.
Yao NH; Liu G; He WY; Niu C; Carlson JR; Lam KS
Bioorg Med Chem Lett; 2005 May; 15(9):2325-9. PubMed ID: 15837318
[TBL] [Abstract][Full Text] [Related]
4. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of teicoplanin against Clostridium difficile.
Wongwanich S; Kusum M; Phan-Urai R
Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):606-9. PubMed ID: 9185278
[TBL] [Abstract][Full Text] [Related]
6. [Recent advances in the study of synthesis and activity of vancomycin derivatives].
Chen YY; Liu G
Yao Xue Xue Bao; 2007 May; 42(5):463-9. PubMed ID: 17703765
[TBL] [Abstract][Full Text] [Related]
7. Identification of potent and broad-spectrum antibiotics from SAR studies of a synthetic vancomycin analogue.
Ahrendt KA; Olsen JA; Wakao M; Trias J; Ellman JA
Bioorg Med Chem Lett; 2003 May; 13(10):1683-6. PubMed ID: 12729641
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.
O'Connor R; Baines SD; Freeman J; Wilcox MH
J Antimicrob Chemother; 2008 Oct; 62(4):762-5. PubMed ID: 18606787
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic activities and affinities for bacterial cell wall analogue of N-demethylvancomycin and its derivatives.
Yan H; Qi D; Cheng X; Song Z; Li W; He B
J Antibiot (Tokyo); 1998 Aug; 51(8):750-6. PubMed ID: 9766467
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria.
Nakama Y; Yoshida O; Yoda M; Araki K; Sawada Y; Nakamura J; Xu S; Miura K; Maki H; Arimoto H
J Med Chem; 2010 Mar; 53(6):2528-33. PubMed ID: 20180534
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, SAR, and antibacterial activity of novel oxazolidinone analogues possessing urea functionality.
Selvakumar N; Rajulu GG; Reddy KC; Chary BC; Kumar PK; Madhavi T; Praveena K; Reddy KH; Takhi M; Mallick A; Amarnath PV; Kandepu S; Iqbal J
Bioorg Med Chem Lett; 2008 Jan; 18(2):856-60. PubMed ID: 18155521
[TBL] [Abstract][Full Text] [Related]
12. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers.
Griffin JH; Linsell MS; Nodwell MB; Chen Q; Pace JL; Quast KL; Krause KM; Farrington L; Wu TX; Higgins DL; Jenkins TE; Christensen BG; Judice JK
J Am Chem Soc; 2003 May; 125(21):6517-31. PubMed ID: 12785792
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile.
Goldstein EJ; Citron DM; Tyrrell KL; Warren YA
Anaerobe; 2010 Jun; 16(3):220-2. PubMed ID: 20044011
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria.
Nakamura J; Yamashiro H; Hayashi S; Yamamoto M; Miura K; Xu S; Doi T; Maki H; Yoshida O; Arimoto H
Chemistry; 2012 Oct; 18(40):12681-9. PubMed ID: 22915313
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.
Tyrrell KL; Citron DM; Warren YA; Fernandez HT; Merriam CV; Goldstein EJ
Antimicrob Agents Chemother; 2006 Aug; 50(8):2728-31. PubMed ID: 16870765
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target-accelerated combinatorial synthesis.
Nicolaou KC; Hughes R; Cho SY; Winssinger N; Labischinski H; Endermann R
Chemistry; 2001 Sep; 7(17):3824-43. PubMed ID: 11575783
[TBL] [Abstract][Full Text] [Related]
18. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
Macielag MJ; Demers JP; Fraga-Spano SA; Hlasta DJ; Johnson SG; Kanojia RM; Russell RK; Sui Z; Weidner-Wells MA; Werblood H; Foleno BD; Goldschmidt RM; Loeloff MJ; Webb GC; Barrett JF
J Med Chem; 1998 Jul; 41(16):2939-45. PubMed ID: 9685233
[TBL] [Abstract][Full Text] [Related]
19. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
[TBL] [Abstract][Full Text] [Related]
20. Multivalent antibiotics via metal complexes: potent divalent vancomycins against vancomycin-resistant enterococci.
Xing B; Yu CW; Ho PL; Chow KH; Cheung T; Gu H; Cai Z; Xu B
J Med Chem; 2003 Nov; 46(23):4904-9. PubMed ID: 14584941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
